Oniria (Zolpidem Tartrate)

Zolpidem tartrate is used to manage sleep initiation problems within the broader category of insomnia disorders.

• Insomnia (sleep onset insomnia): Helps patients fall asleep more quickly.
• Transient insomnia due to stress or jet‑lag: Provides short‑term relief of difficulty falling asleep.
• Primary sleep disorder: Improves overall sleep latency in diagnosed primary insomnia.

• Zolpidem tartrate binds selectively to the benzodiazepine‑binding site of the GABA‑A receptor complex, enhancing the inhibitory effect of GABA. This potentiation increases chloride ion influx, leading to neuronal hyperpolarisation and a reduction in central nervous system activity that promotes sleep onset.

Adverse reactions to zolpidem are reported across a range of frequencies.

Common Side Effects

• Drowsiness: Persistent sleepiness during waking hours.
• Dizziness: Light‑headed sensation, especially when standing quickly.
• Headache: Mild to moderate head pain.
• Nausea: Stomach discomfort or urge to vomit.
• Dry mouth: Reduced salivation.
• Unpleasant taste: Metallic or bitter sensation in the mouth.

Serious or Rare Side Effects

• Complex sleep‑related behaviours: Sleepwalking, sleep‑driving or other activities while not fully awake.
• Allergic reactions: Rash, itching, swelling, or difficulty breathing.
• Depression or mood changes: Worsening depressive symptoms or new onset mood disturbances.
• Hallucinations: Visual or auditory disturbances.
• Suicidal thoughts: Emergence of suicidal ideation.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

When prescribing zolpidem, clinicians should consider several safety aspects.

• Assess sleep disorder duration: Confirm that use is limited to short‑term therapy (typically ≤ 7 days).
• Evaluate comorbid conditions: Review psychiatric, respiratory or hepatic disorders before initiating therapy.
• Avoid alcohol: Concomitant alcohol use can amplify sedative effects and increase risk of respiratory depression.
• Monitor for dependence: Watch for signs of tolerance, misuse or withdrawal with prolonged use.
• Counsel on next‑day activities: Advise patients to ensure a full night’s sleep before driving or operating machinery.
• Store at ambient temperature: Keep tablets in the original container, protect from moisture and heat.

Zolpidem may interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

• Opioids: Combined use can increase risk of profound sedation and respiratory depression.
• Central nervous system depressants: Concurrent benzodiazepines or barbiturates may cause excessive sedation.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): May raise zolpidem plasma concentrations.

Moderate Interactions (Monitor Closely)

• Antidepressants (especially SSRIs): May augment sleep‑related side effects.
• Antihistamines: Can enhance drowsiness.
• Alcohol: Even moderate intake can intensify sedation and impair cognition.